737 related articles for article (PubMed ID: 11394392)
1. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N
J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392
[TBL] [Abstract][Full Text] [Related]
2. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
[TBL] [Abstract][Full Text] [Related]
3. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
[TBL] [Abstract][Full Text] [Related]
4. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
[TBL] [Abstract][Full Text] [Related]
5. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans.
Lekovic V; Camargo PM; Weinlaender M; Nedic M; Aleksic Z; Kenney EB
J Periodontol; 2000 Jul; 71(7):1110-6. PubMed ID: 10960017
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Kenney EB; Madzarevic M
J Clin Periodontol; 2001 Nov; 28(11):1016-22. PubMed ID: 11686822
[TBL] [Abstract][Full Text] [Related]
7. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
Int J Periodontics Restorative Dent; 2005 Feb; 25(1):49-59. PubMed ID: 15736778
[TBL] [Abstract][Full Text] [Related]
8. A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Nedic M; Vasilic N; Wolinsky LE; Kenney EB
J Clin Periodontol; 2000 Dec; 27(12):889-96. PubMed ID: 11140555
[TBL] [Abstract][Full Text] [Related]
9. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
[TBL] [Abstract][Full Text] [Related]
11. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects.
Lekovic V; Milinkovic I; Aleksic Z; Jankovic S; Stankovic P; Kenney EB; Camargo PM
J Periodontal Res; 2012 Aug; 47(4):409-17. PubMed ID: 22126591
[TBL] [Abstract][Full Text] [Related]
12. Clinical and radiographic evaluation of regenerative potential of GTR membrane (Biomesh®) along with alloplastic bone graft (Biograft®) in the treatment of periodontal intrabony defects.
Mopur JM; Devi TR; Ali SM; Srinivasa TS; Gopinath V; Salam AR
J Contemp Dent Pract; 2013 May; 14(3):434-9. PubMed ID: 24171985
[TBL] [Abstract][Full Text] [Related]
13. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
14. GTR treatment of intrabony defects with PLA/PGA copolymer or collagen bioresorbable membranes in combination with deproteinized bovine bone (Bio-Oss).
Stavropoulos A; Sculean A; Karring T
Clin Oral Investig; 2004 Dec; 8(4):226-32. PubMed ID: 15583920
[TBL] [Abstract][Full Text] [Related]
15. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
[TBL] [Abstract][Full Text] [Related]
17. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
18. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
Zucchelli G; Bernardi F; Montebugnoli L; De SM
J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
[TBL] [Abstract][Full Text] [Related]
19. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
